John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.